NCT05108688View on ClinicalTrials.gov

Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions
Headache
Interventions
DRUG

Mirtazapine

Mirtazapine 30 mg tablet once daily for 3 successive days

DRUG

Sumatriptan

Sumatriptan 50 mg tablet once daily for 3 successive days

OTHER

Placebo

Placebo tablets once daily for 3 successive days.

Trial Locations (1)

Unknown

Ain-Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05108688 - Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache | Biotech Hunter | Biotech Hunter